Development and validation of a self-reported cognitive measure (Meno-Cog) for perimenopause

Abstract Brain fog related issues are amongst the most prevalent symptoms reported during the menopause transition (MT). The Menopause-specific Cognitive Scale (Meno-Cog) is a subjective measure of cognitive function and was developed via a narrative review, focus groups, and expert consultations, to characterise cognitive symptoms at MT. The current study aims to validate the Meno-Cog in women during the MT. An online survey study was conducted to collect responses to Meno-Cog and other measures to assess construct validity. Normality of the score distribution, floor and ceiling effects, construct validity, and internal consistency were assessed. An exploratory factor analysis was conducted for item selection, followed by a confirmatory factor analysis as a gold standard to confirm the prespecified factor structure. Data from a separate feasibility trial were used to assess the responsiveness of Meno-Cog. Analyses of 247 responses from women in the MT demonstrated excellent internal consistency and construct validity, with no missing data observed. No significant floor/ceiling effects were found in the total scores, but there were some within individual items. A four-factor model with adequate fit was suggested by factor analysis. Responsiveness to change remained unclear. The Meno-Cog was developed by drawing on knowledge of the cognitive domains potentially impacted by the MT. It demonstrated adequate to excellent psychometric properties through robust statistical analyses. Future research will extend the validation to women from more diverse backgrounds for generalisability, and to explore its use in clinical settings. Lay summary Cognitive issues, such as forgetfulness and difficulty concentrating, are often reported during the menopause transition. However, current understanding of women’s cognitive experiences is often restricted to memory issues; other experiences, such as struggling with multitasking, are largely neglected. This may show a knowledge gap in women’s cognitive health and highlight potential unmet needs during this transition. We developed and assessed the quality of a self-reported cognitive scale, the Menopause-Specific Cognitive Scale (Meno-Cog), which measures a diverse range of everyday cognitive challenges relevant to the menopause transition. The Meno-Cog was shown to be a reliable and useful tool for women going through the menopause transition. This scale will be helpful in understanding cognitive experiences during the menopause transition, monitoring treatment progress, identifying any unmet needs, and potentially improving the quality of menopause care. Future research should also explore the use of Meno-Cog with women from more diverse backgrounds.

Authors

Institutions

Publication Details

Journal
Reproduction and Fertility
Published
2026-11-17
DOI
https://doi.org/10.1530/raf-26-0115
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and validation of a self-reported cognitive measure (Meno-Cog) for perimenopause

Aimee E Spector, Nicole G. Jaff, Céline El Baou, Charlotte R. Stoner et al.
5 links
Reproduction and Fertility
Menopause: Health Impacts and Treatments
article

Development and validation of a self-reported cognitive measure (Meno-Cog) for perimenopause

Aimee E Spector, Nicole G. Jaff, Céline El Baou, Charlotte R. Stoner, Lexi He
article en

Abstract

Abstract Brain fog related issues are amongst the most prevalent symptoms reported during the menopause transition (MT). The Menopause-specific Cognitive Scale (Meno-Cog) is a subjective measure of cognitive function and was developed via a narrative review, focus groups, and expert consultations, to characterise cognitive symptoms at MT. The current study aims to validate the Meno-Cog in women during the MT. An online survey study was conducted to collect responses to Meno-Cog and other measures to assess construct validity. Normality of the score distribution, floor and ceiling effects, construct validity, and internal consistency were assessed. An exploratory factor analysis was conducted for item selection, followed by a confirmatory factor analysis as a gold standard to confirm the prespecified factor structure. Data from a separate feasibility trial were used to assess the responsiveness of Meno-Cog. Analyses of 247 responses from women in the MT demonstrated excellent internal consistency and construct validity, with no missing data observed. No significant floor/ceiling effects were found in the total scores, but there were some within individual items. A four-factor model with adequate fit was suggested by factor analysis. Responsiveness to change remained unclear. The Meno-Cog was developed by drawing on knowledge of the cognitive domains potentially impacted by the MT. It demonstrated adequate to excellent psychometric properties through robust statistical analyses. Future research will extend the validation to women from more diverse backgrounds for generalisability, and to explore its use in clinical settings. Lay summary Cognitive issues, such as forgetfulness and difficulty concentrating, are often reported during the menopause transition. However, current understanding of women’s cognitive experiences is often restricted to memory issues; other experiences, such as struggling with multitasking, are largely neglected. This may show a knowledge gap in women’s cognitive health and highlight potential unmet needs during this transition. We developed and assessed the quality of a self-reported cognitive scale, the Menopause-Specific Cognitive Scale (Meno-Cog), which measures a diverse range of everyday cognitive challenges relevant to the menopause transition. The Meno-Cog was shown to be a reliable and useful tool for women going through the menopause transition. This scale will be helpful in understanding cognitive experiences during the menopause transition, monitoring treatment progress, identifying any unmet needs, and potentially improving the quality of menopause care. Future research should also explore the use of Meno-Cog with women from more diverse backgrounds.

Reproduction and Fertility
National Health Laboratory Service (ZA), University of West London (GB), University of the Witwatersrand (ZA), University College London (GB)
Good health and well-being
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon